Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Damon Runyon identifies scientists with the highest potential to revolutionize how we prevent, diagnose, and treat all forms of cancer.
A mathematical technique called matrix completion could speed up the development of vaccines for flu and COVID-19 variants.
Blood and skin cancers are more sensitive to inhibiting the CDK6 protein. Breast, lung, colorectal and other cancers are linked to CDK4.
This cross-species spatial analysis of the brain is the first of its kind.
“We want to find the least intense treatment with the least amount of toxicity that effectively will cure the patient."
Researchers zoom in on a tiny brain structure called the area postrema, where the sensation of nausea is “felt.”
Most pancreatic cancer cells have relatively few mutations on their surface to attract the attention of cancer-killing immune T cells.
With a better understanding of why certain NRAS mutants are linked to melanoma, researchers can target functions exclusive to these proteins
Targeting the genes and pathways that promote liver metastasis may be key to developing better treatments for colorectal cancer.
Understanding the evolutionary path that tumors follow is essential for designing effective clinical interventions.
A new approach to prognosis looks to patients’ genomes for clues about how their cancer will behave.
Researchers identify a number of genes that contribute to the development of liver cancer in Beckwith-Wiedemann Syndrome.
Watch groundbreaking scientists share their experiences and explain how Damon Runyon funding makes a difference in cancer research.
Researchers developed a new tool, the EPIC-seq, that can diagnose cancer subtypes from patient blood samples.
A look at the scientists behind David Julius’s Nobel Prize for discoveries regarding the proteins that help us sense temperature and pain.
A discovery in how cells absorb substances provides insights into certain cancers and may be applied to therapeutic drugs.
Known as a carbon nanotube, the implant can detect cancer-associated proteins and alert a devise outside the body.
“While this approach is not restricted to analyzing tumor tissues, there are obvious applications for better understanding cancer."
Over the past decade, the field of mRNA therapeutics has advanced rapidly.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.